Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids

Residual macrovascular risk in 2013: what have we learned?

(2014) Jean-Charles Fruchart et al.   Cardiovascular Diabetology

Lipoprotein remnants and dense LDL are associated with features of unstable carotid plaque: A flag for non-HDL-C

(2013) Alberto Zambon et al.   ATHEROSCLEROSIS

Very Large Database of Lipids: Rationale and Design

(2013) Seth S. Martin et al.   CLINICAL CARDIOLOGY

Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile

(2013) Seth S. Martin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications

(2013) Seth S. Martin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction

(2012) Alexander Tenenbaum et al.   Cardiovascular Diabetology

Effect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial

(2012) G. Reyes-Soffer et al.   DIABETES CARE

Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction

(2012) Anders Berg Jørgensen et al.   EUROPEAN HEART JOURNAL

Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels

(2012) Laurent Querton et al.   Journal of Clinical Lipidology

The multi-faceted outcomes of conjunct diabetes and cardiovascular familial history in type 2 diabetes

(2012) Michel P. Hermans et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Remnant Cholesterol

(2012) Ruth McPherson   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

(2012) Anette Varbo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females

(2012) Michel P Hermans et al.   Lipids in Health and Disease

log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males

(2011) Michel P Hermans et al.   Cardiovascular Diabetology

Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence

(2011) Michel P Hermans et al.   Cardiovascular Diabetology

Remnant Lipoproteins As Strong Key Particles to Atherogenesis

(2011) Yoshio Fujioka et al.   Journal of Atherosclerosis and Thrombosis

Opening a New Lipid “Apo-thecary”: Incorporating Apolipoproteins as Potential Risk Factors and Treatment Targets to Reduce Cardiovascular Risk

(2011) Terry A. Jacobson   MAYO CLINIC PROCEEDINGS

Implications of the ACCORD Lipid study: perspective from the Residual Risk Reduction Initiative (R3i)

(2010) J.C. Fruchart et al.   CURRENT MEDICAL RESEARCH AND OPINION

Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care

(2010) Kurt Bestehorn et al.   CURRENT MEDICAL RESEARCH AND OPINION

Non-HDL-cholesterol/apolipoprotein B ratio: A useful distinguishing feature in the screening for type III hyperlipoproteinemia

(2010) Toshio Murase et al.   Journal of Clinical Lipidology

Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up

(2010) A. Langsted et al.   JOURNAL OF INTERNAL MEDICINE

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

Triglycerides as vascular risk factors: new epidemiologic insights

(2009) William B Kannel et al.   CURRENT OPINION IN CARDIOLOGY

Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation

(2008) J. D. Brunzell et al.   DIABETES CARE